BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 28985291)

  • 1. Mobile Genetic Elements and Evolution of CRISPR-Cas Systems: All the Way There and Back.
    Koonin EV; Makarova KS
    Genome Biol Evol; 2017 Oct; 9(10):2812-2825. PubMed ID: 28985291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phylogenomics of Cas4 family nucleases.
    Hudaiberdiev S; Shmakov S; Wolf YI; Terns MP; Makarova KS; Koonin EV
    BMC Evol Biol; 2017 Nov; 17(1):232. PubMed ID: 29179671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Origins and evolution of CRISPR-Cas systems.
    Koonin EV; Makarova KS
    Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180087. PubMed ID: 30905284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recruitment of CRISPR-Cas systems by Tn7-like transposons.
    Peters JE; Makarova KS; Shmakov S; Koonin EV
    Proc Natl Acad Sci U S A; 2017 Aug; 114(35):E7358-E7366. PubMed ID: 28811374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Casposons: a new superfamily of self-synthesizing DNA transposons at the origin of prokaryotic CRISPR-Cas immunity.
    Krupovic M; Makarova KS; Forterre P; Prangishvili D; Koonin EV
    BMC Biol; 2014 May; 12():36. PubMed ID: 24884953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unprecedented Diversity of Unique CRISPR-Cas-Related Systems and Cas1 Homologs in Asgard Archaea.
    Makarova KS; Wolf YI; Shmakov SA; Liu Y; Li M; Koonin EV
    CRISPR J; 2020 Jun; 3(3):156-163. PubMed ID: 33555973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Mobility of Casposons, Self-Synthesizing Transposons at the Origin of the CRISPR-Cas Immunity.
    Krupovic M; Shmakov S; Makarova KS; Forterre P; Koonin EV
    Genome Biol Evol; 2016 Jan; 8(2):375-86. PubMed ID: 26764427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CRISPR Spacer Space Is Dominated by Sequences from Species-Specific Mobilomes.
    Shmakov SA; Sitnik V; Makarova KS; Wolf YI; Severinov KV; Koonin EV
    mBio; 2017 Sep; 8(5):. PubMed ID: 28928211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diversity and evolution of class 2 CRISPR-Cas systems.
    Shmakov S; Smargon A; Scott D; Cox D; Pyzocha N; Yan W; Abudayyeh OO; Gootenberg JS; Makarova KS; Wolf YI; Severinov K; Zhang F; Koonin EV
    Nat Rev Microbiol; 2017 Mar; 15(3):169-182. PubMed ID: 28111461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR-Cas systems: beyond adaptive immunity.
    Westra ER; Buckling A; Fineran PC
    Nat Rev Microbiol; 2014 May; 12(5):317-26. PubMed ID: 24704746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR-Cas in mobile genetic elements: counter-defence and beyond.
    Faure G; Shmakov SA; Yan WX; Cheng DR; Scott DA; Peters JE; Makarova KS; Koonin EV
    Nat Rev Microbiol; 2019 Aug; 17(8):513-525. PubMed ID: 31165781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis of CRISPR-Cas Type III prokaryotic defence systems.
    Molina R; Sofos N; Montoya G
    Curr Opin Struct Biol; 2020 Dec; 65():119-129. PubMed ID: 32712502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diversity, classification and evolution of CRISPR-Cas systems.
    Koonin EV; Makarova KS; Zhang F
    Curr Opin Microbiol; 2017 Jun; 37():67-78. PubMed ID: 28605718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the Origin of Reverse Transcriptase-Using CRISPR-Cas Systems and Their Hyperdiverse, Enigmatic Spacer Repertoires.
    Silas S; Makarova KS; Shmakov S; Páez-Espino D; Mohr G; Liu Y; Davison M; Roux S; Krishnamurthy SR; Fu BXH; Hansen LL; Wang D; Sullivan MB; Millard A; Clokie MR; Bhaya D; Lambowitz AM; Kyrpides NC; Koonin EV; Fire AZ
    mBio; 2017 Jul; 8(4):. PubMed ID: 28698278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolutionary and mechanistic diversity of Type I-F CRISPR-associated transposons.
    Klompe SE; Jaber N; Beh LY; Mohabir JT; Bernheim A; Sternberg SH
    Mol Cell; 2022 Feb; 82(3):616-628.e5. PubMed ID: 35051352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transposon-encoded CRISPR-Cas systems direct RNA-guided DNA integration.
    Klompe SE; Vo PLH; Halpin-Healy TS; Sternberg SH
    Nature; 2019 Jul; 571(7764):219-225. PubMed ID: 31189177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cas1 and Cas2 From the Type II-C CRISPR-Cas System of
    He Y; Wang M; Liu M; Huang L; Liu C; Zhang X; Yi H; Cheng A; Zhu D; Yang Q; Wu Y; Zhao X; Chen S; Jia R; Zhang S; Liu Y; Yu Y; Zhang L
    Front Cell Infect Microbiol; 2018; 8():195. PubMed ID: 29951376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classification and evolution of type II CRISPR-Cas systems.
    Chylinski K; Makarova KS; Charpentier E; Koonin EV
    Nucleic Acids Res; 2014 Jun; 42(10):6091-105. PubMed ID: 24728998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR-Cas systems are present predominantly on mobile genetic elements in Vibrio species.
    McDonald ND; Regmi A; Morreale DP; Borowski JD; Boyd EF
    BMC Genomics; 2019 Feb; 20(1):105. PubMed ID: 30717668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPRCasdb a successor of CRISPRdb containing CRISPR arrays and cas genes from complete genome sequences, and tools to download and query lists of repeats and spacers.
    Pourcel C; Touchon M; Villeriot N; Vernadet JP; Couvin D; Toffano-Nioche C; Vergnaud G
    Nucleic Acids Res; 2020 Jan; 48(D1):D535-D544. PubMed ID: 31624845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.